Healthcare - Biotechnology - NASDAQ - US
$ 0.0959
-8.32 %
$ 10.4 M
Market Cap
-0.64
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
98.71%
EBIT
Estimate
38.82%
Net Income
Estimate
12.18%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Apollomics, Inc.
APLM has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart APLM
EBIT FORECAST
EBIT Forecast Chart APLM
NET INCOME FORECAST
Net Income Chart APLM